The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical value of measuring T-cell activation and proliferation using multiplexed quantitative fluorescence in non-small cell lung cancer (NSCLC).
 
Kurt Alex Schalper
No Relationships to Disclose
 
Nikita Mani
No Relationships to Disclose
 
Maria Toki
No Relationships to Disclose
 
Daniel E. Carvajal-Hausdorf
No Relationships to Disclose
 
Roy S. Herbst
Honoraria - AstraZeneca/MedImmune; Boehringer Ingelheim; Bristol-Myers Squibb; Genentech/Roche; Lilly; Merck; NovaRX; pfizer
Consulting or Advisory Role - Biothera; DiaTech Oncology; Endocyte; Kolltan Pharmaceuticals; N-of-One
Research Funding - Genentech/Roche
 
David L. Rimm
Leadership - MDAgree
Stock and Other Ownership Interests - Metamark Genetics
Honoraria - ACD Pharmaceuticals; Amgen; AstraZeneca; Bristol-Myers Squibb
Consulting or Advisory Role - Biocept; Cernostics; Genoptix; Perkin Elmer
Research Funding - Cepheid; Gilead Sciences; Kolltan Pharmaceuticals; OncoPlex Diagnostics; Perkin Elmer
Patents, Royalties, Other Intellectual Property - Quantitative Immunofluorescence (AQUA) (Inst); Rarecyte Circulating tumor cells
Travel, Accommodations, Expenses - Ventana Medical Systems